Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

WILLIAM BARRY LEE

Allopathic & Osteopathic Physicians Ophthalmology Cornea and External Diseases Specialist

NPI
1366406787
CMS profile
152779
Location
ATLANTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$80,189.56

145 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 145 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

WILLIAM BARRY LEE

NPI 1366406787 · CMS profile ID 152779

Allopathic & Osteopathic Physicians / Ophthalmology / Cornea and External Diseases Specialist

ATLANTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 145 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1366406787?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
WILLIAM BARRY LEE, NPI 1366406787, CMS profile ID 152779. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 145 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1366406787?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). WILLIAM BARRY LEE, NPI 1366406787, CMS profile ID 152779. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 145 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1366406787?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
WILLIAM BARRY LEE, NPI 1366406787, CMS profile ID 152779, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 145 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1366406787?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

145 matching records · $80,189.56 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 145 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 145.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Sun Pharmaceutical Industries Inc. $187.6610/11/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053998909 CMS
Bausch & Lomb Americas Inc. $323.6810/06/2023 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1037894163 CMS
Bausch & Lomb Americas Inc. $111.8910/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1037894217 CMS
Bausch & Lomb Americas Inc. $113.1009/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1037894149 CMS
Oyster Point Pharma, Inc. $4.0509/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052801285 CMS
Bausch & Lomb Americas Inc. $97.6009/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1037894131 CMS
Oyster Point Pharma, Inc. $160.9009/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052801283 CMS
Bausch & Lomb Americas Inc. $864.0209/15/2023 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1037894181 CMS
Glaukos Corporation $18.4909/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059863087 CMS
Sun Pharmaceutical Industries Inc. $3,850.0009/14/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053998859 CMS
Sun Pharmaceutical Industries Inc. $1,401.6109/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053998865 CMS
Sun Pharmaceutical Industries Inc. $78.0009/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053998871 CMS
Johnson & Johnson Surgical Vision, Inc. $12.8209/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 990947809 CMS
Bausch & Lomb Americas Inc. $417.8109/12/2023 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1037894207 CMS
Novartis Pharmaceuticals Corporation $3.4309/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992224767 CMS
Bausch & Lomb Americas Inc. $22.2808/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1037894253 CMS
Dompe US, Inc. $2,800.0008/29/2023 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055253343 CMS
Novartis Pharmaceuticals Corporation $20.4808/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992224765 CMS
Bausch & Lomb Americas Inc. $991.9808/28/2023 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1037894141 CMS
Novartis Pharmaceuticals Corporation $2.5008/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992224761 CMS
Oyster Point Pharma, Inc. $4.9008/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052801281 CMS
Bausch & Lomb Americas Inc. $1,115.9808/18/2023 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1037894137 CMS
Novartis Pharmaceuticals Corporation $21.9508/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992224757 CMS
Johnson & Johnson Surgical Vision, Inc. $91.1508/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 990947801 CMS
Sun Pharmaceutical Industries Inc. $138.6008/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053998815 CMS
ABBVIE INC. $22.8408/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997748779 CMS
Glaukos Corporation $22.8607/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059863083 CMS
Glaukos Corporation $145.9207/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059863085 CMS
Oyster Point Pharma, Inc. $6.9707/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052801279 CMS
Dompe US, Inc. $123.2607/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055253341 CMS
Novartis Pharmaceuticals Corporation $16.1307/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992224753 CMS
Novartis Pharmaceuticals Corporation $7.7307/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992224749 CMS
Novartis Pharmaceuticals Corporation $2.3507/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992224745 CMS
Alcon Vision LLC $117.4807/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995679239 CMS
Alcon Vision LLC $23.2607/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995679211 CMS
Alcon Vision LLC $125.0307/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995679247 CMS
Alcon Vision LLC $145.0807/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995679261 CMS
Glaukos Corporation $51.2207/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059863081 CMS
Alcon Vision LLC $27.3807/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995679219 CMS
Oyster Point Pharma, Inc. $13.2307/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052801277 CMS
Bausch & Lomb Americas Inc. $0.2706/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1037894247 CMS
Bausch & Lomb Americas Inc. $22.3506/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1037894249 CMS
ABBVIE INC. $17.0106/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997748777 CMS
Glaukos Corporation $9.1406/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059863079 CMS
Dompe US, Inc. $1,050.0006/20/2023 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055253339 CMS
Glaukos Corporation $9.0206/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059863077 CMS
Novartis Pharmaceuticals Corporation $3.5406/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992224741 CMS
Sun Pharmaceutical Industries Inc. $3,850.0006/13/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053998839 CMS
Sun Pharmaceutical Industries Inc. $855.5006/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053998845 CMS
Sun Pharmaceutical Industries Inc. $96.3406/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053998851 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $90,160.48 152
PY2020 $46,842.02 96
PY2021 $70,498.48 162
PY2022 $81,899.86 168
PY2023 $80,189.56 145
PY2024 $43,659.95 135
PY2025 $88,076.55 156

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $17,649.00 8
PY2024 Principal investigator $4,677.00 3
PY2023 Principal investigator $962.50 2
PY2022 Principal investigator $20,629.66 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Oyster Point Pharma, Inc. $1,638.00 10/15/2025 Non-covered Recipient Entity
Eye Consultants of Atlanta PC
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522450
Principal investigator 1 Oyster Point Pharma, Inc. $3,144.60 10/15/2025 Non-covered Recipient Entity
Eye Consultants of Atlanta PC
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522452
Principal investigator 1 Oyster Point Pharma, Inc. $1,611.00 08/14/2025 Non-covered Recipient Entity
Eye Consultants of Atlanta PC
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522448
Principal investigator 1 Oyster Point Pharma, Inc. $1,778.40 06/13/2025 Non-covered Recipient Entity
Eye Consultants of Atlanta PC
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522442
Principal investigator 1 Oyster Point Pharma, Inc. $1,778.40 04/28/2025 Non-covered Recipient Entity
Eye Consultants of Atlanta PC
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522444
Principal investigator 1 Oyster Point Pharma, Inc. $1,724.40 03/19/2025 Non-covered Recipient Entity
Eye Consultants of Atlanta PC
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522440
Principal investigator 1 Oyster Point Pharma, Inc. $1,864.80 02/10/2025 Non-covered Recipient Entity
Eye Consultants of Atlanta PC
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522438
Principal investigator 1 Oyster Point Pharma, Inc. $4,109.40 01/17/2025 Non-covered Recipient Entity
Eye Consultants of Atlanta PC
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522436